| Literature DB >> 33102810 |
Atiporn Therdyothin1, Nacharin Phiphopthatsanee2, Wiwat Wajanavisit1, Patarawan Woratanarat1, Sukij Laohajaroensombat1, Tulyapruek Tawonsawatruk1.
Abstract
OBJECTIVES: Ankle fractures are common in the elderly. However, their association with osteoporosis remains controversial. This systematic review aims to determine the relationship between ankle fracture and bone mineral density (BMD), and to investigate the risk of subsequent fractures after ankle fracture.Entities:
Keywords: Ankle fracture; Bone mineral density; Fracture prediction; Osteoporosis; Risk factor
Year: 2020 PMID: 33102810 PMCID: PMC7573497 DOI: 10.1016/j.afos.2020.08.003
Source DB: PubMed Journal: Osteoporos Sarcopenia ISSN: 2405-5255
Fig. 1PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analysis.
Quality assessment of studies included in this systematic review.
| Study [Reference] | Study design | Score awarded/Full score | Percent (%) | |||
|---|---|---|---|---|---|---|
| Selection | Comparability | Exposure/Outcome | Total | |||
| Biver E [ | Cross-sectional | 2/4 | 2/2 | 2/2 | 6/8 | 75.0 |
| Center JR [ | Prospective cohort | 4/4 | 0/2 | 3/3 | 7/9 | 77.78 |
| Ettinger B [ | Prospective cohort | 4/4 | 2/2 | 2/3 | 8/9 | 88.89 |
| Gehlbach S [ | Prospective cohort | 3/4 | 1/2 | 2/3 | 6/9 | 66.67 |
| Gnudi S [ | Prospective cohort | 3/4 | 1/2 | 2/3 | 6/9 | 66.67 |
| Gnudi S [ | Cross-sectional | 3/4 | 0/2 | 2/2 | 5/8 | 62.5 |
| Greenfield DM [ | Cross-sectional | 3/4 | 2/2 | 2/2 | 7/8 | 87.5 |
| Ho PY [ | Case control | 3/4 | 1/2 | 1/3 | 5/9 | 55.56 |
| Ingle BM [ | Cross sectional | 4/4 | 1/2 | 2/2 | 7/8 | 87.5 |
| Lauritzen JB [ | Prospective cohort | 3/4 | 2/2 | 1/3 | 5/9 | 55.56 |
| Lee DO [ | Case-control | 3/4 | 1/2 | 2/2 | 6/8 | 75.0 |
| Morin SN [ | Retrospective cohort | 4/4 | 2/2 | 2/3 | 8/9 | 88.89 |
| Pritchard JM [ | Prospective cohort | 4/4 | 2/2 | 1/3 | 7/9 | 77.78 |
| Robinson CM [ | Prospective cohort | 4/4 | 2/2 | 1/3 | 7/9 | 77.78 |
| Schuit SC [ | Prospective cohort | 3/4 | 1/2 | 2/3 | 6/9 | 66.67 |
| Seeley DG [ | Prospective cohort | 4/4 | 2/2 | 2/3 | 8/9 | 88.89 |
| Stein EM [ | Cross-sectional | 3/4 | 0/2 | 2/2 | 5/8 | 62.5 |
| Stone K [ | Prospective cohort | 3/4 | 1/2 | 3/3 | 7/9 | 77.78 |
| Taylor AJ [ | Retrospective cohort | 3/4 | 2/2 | 1/3 | 6/9 | 66.67 |
List of studies investigating the relationship between ankle fracture and subsequent fracture.
| Study [Reference] | Study design | Study population | Total sample | Average time of follow-up, yr) | Initial ankle fracture case | Initial non-fracture case | Associated/Subsequent fracture type | Subsequent fracture case | Type of risk | Value (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|
| Biver E [ | Cross-sectional | Geneva Retirees Cohort, Switzerland (female, mean 65 yr) | 749 | N/A | 63 | 433 | Any | N/A | OR | 2.08 (1.24–3.5) P = 0.006 |
| Fragility fracture | N/A | 1.89 (1.04–3.44) P = 0.037 | ||||||||
| Center JR [ | Prospective cohort | Dubbo Osteoporosis Epidemiology Study, Australia (female and male aged ≥ 60 yr) | Total 4005 | |||||||
| Female 2245 | 16 | 905 initial fracture, no specified data for ankle fracture | 1340 | Any | 253 after all initial fracture, 7 after ankle fracture | RR | 0.84 (0.4–1.78) | |||
| Male 1760 | 15 | 337 initial fracture, no specified data for ankle fracture | 1423 | Any | 71 after all initial fracture, 10 after ankle fracture | 4.59 (2.45–8.61) | ||||
| Ettinger B [ | Prospective cohort | Northern California, USA, retrieved from the Kaiser Permanente Medical care program (male ≥ 60 yr) | 90825 | 2.4 | 1067 | Normal population 86408 | Ankle, hip, humerus, wrist | N/A | HR after adjust for all - age, cardiac related drug use, central nervous system related drug use, DM drug use, hospitalization, office visit | 1 (0.5–1.9) |
| Finger fracture 841 | Ankle, hip, humerus, wrist | N/A | 1 (0.4–2.6) | |||||||
| GehlbachS [ | Prospective cohort | Global Longitudinal Study of Osteoporosis in Women (GLOW), 10 countries (female, mean age 68 yr) | 51762 | 2 | 3201 | 39753 | Any | N/A | HR adjusted for age, physician practice site, multiple previous fractures | 1.4 (1.24–1.58) |
| Hip | N/A | 1.45 (0.95–2.2) | ||||||||
| Spine | N/A | 1.24 (0.86–1.8) | ||||||||
| Other weight bearing bone | N/A | 1.83 (1.52–2.19) | ||||||||
| Non-weight bearing bone | N/A | 1.15 (0.95–1.39) | ||||||||
| Greenfield DM [ | Cross-sectional | Postmenopausal women recruited at Northern General Hospital Trust, Sheffield, England (female, mean age 64.2) | 478 | N/A | 103 | 375 | Distal forearm | 26% | OR | 2.82 |
| Hip | 2% | 1.84 | ||||||||
| Spine | 10% | 1.43 | ||||||||
| Ingle BM [ | Cross sectional | Postmenopausal women recruited at Northern General Hospital Trust, Sheffield, England (female, mean age 62.2) | 62 | N/A | 31 | 31 | Distal forearm | 24% | OR | 3.63 |
| Hip | 2% | 2.02 | ||||||||
| Lauritzen JB [ | Prospective cohort | Inpatient at Hvidovre Hospital, Copenhagen, Denmark (admitted fracture lumbar spine, knee, ankle) (female aged 60–99) | 451 | Median 3.6 (from initial ankle fracture) | Total 200 | Hip | 8 | RR | 1.3 (0.6–2.7) | |
| Aged 60–79, 182 | Hip | 7 | 1.5 (0.6–3.1) | |||||||
| Aged 80–99, 18 | Hip | 1 | 0.7 (0.02–4.0) | |||||||
| Morin SN [ | Retrospective cohort | Women undergoing baseline clinical BMD from 1990 to 2007 from the database of Manitoba, Canada (female, mean age 64.3) | 39991 | 5.3 | 1694 | 29878 | Major osteoporotic fracture | N/A | HR adjusted for decades of age, femoral neck BMD | 1.3 (1.08–1.57) |
| Pritchard JM [ | Prospective cohort | Females with or without DM from Population Health Information System (POPULIS) data repository at the Manitoba Centre for Health Policy (MCHP), Canada from 1987 to 2007 | 12205 | 4.8 | 559 | 11646 | Major osteoporotic fracture | 66 | HR adjusted for age, BMI, femoral neck BMD, previous major osteoporotic fracture, number of ADGs 1.17 | (0.79–1.73), P = 0.316 |
| Robinson CM [ | Prospective cohort | Inpatients and outpatients with fracture at Edinburgh Orthopaedic Trauma Unit, Scotland, United Kingdom (female and male aged ≥ 45) | 22060 | 3.6 | 3508 | Baseline population | Hip | N/A | RR | 1.3 (0.95–1.82) |
| Wrist | N/A | 2.03 (1.62–2.51) | ||||||||
| Proximal humerus | N/A | 1.96 (1.32–2.81) | ||||||||
| Ankle | N/A | 4.53 (3.57–5.66) | ||||||||
| Any | N/A | 2.24 (1.89–2.59) | ||||||||
| Taylor AJ [ | Retrospective cohort | 5% random sample of Medicare beneficiaries from 2000 to 2005, obtained from Center of Medicare and Medicaid Services (CMS) Chronic Condition Warehouse | 1694051 | 4.2 person-year | 13454 | 1525735 | Hip | N/A | IRR adjusted for gender, race, age, year, urbanicity, geographic region, income | 0.99 (0.91–1.08) |
| Spine | N/A | 1.14 (1.04–1.25) | ||||||||
| DER + Ulna | N/A | 1.27 (1.12–1.43) | ||||||||
| Humerus | N/A | 0.96 (0.82–1.11) | ||||||||
| Ankle | N/A | N/A | ||||||||
| Tibia + Fibula | N/A | 2.6 (2.19–3.09) |
OR, odds ratio; RR, relative risk; HR, hazard ratio; CI, confidence interval; BMD, bone mineral density; BMI, body mass index; ADG, ambulatory diagnostic group; IRR, incidence rate ratio; DM, diabetes mellitus; N/A, not applicable.
Statistically significant; all ages are in years.
List of studies investigating the relationship between ankle fracture and bone mineral density.
| Study [Reference] | Study design | Study population | Total sample | Average time of follow-up, yr | Initial ankle fracture case | Initial non-fracture case | Subsequent fracture case | BMD mode of measurement | BMD location | BMD fracture (SD) | BMD non-fracture (SD) | Type of risk | Risk of fracture per 1 SD decrease in aBMD (95% CI) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biver E [ | Cross-sectional | Geneva Retirees Cohort, Switzerland (female, mean age 65) | 749 | N/A | 63 | 433 | N/A | Hologic QDR Discovery Instrument | aBMD LS | 0.87 (0.15) | 0.935 (0.152) | OR adjusted for age, height, weight, years after menopause, calcium and protein intake, physical activity adjusted for adjusted for age, height, weight, years after menopause, calcium and protein intake, physical activity age, height, weight, years after menopause, calcium and protein intake, physical activity | 1.92 (1.42–2.60) |
| aBMD FN | 0.678 (0.114) | 0.717 (0.106) | 1.97 (1.42–2.74) | ||||||||||
| aBMD TH | 0.811 (0.107) | 0.855 (0.112) | 2.16 (1.54–3.03)∗ | ||||||||||
| aBMD DER | 0.614 (0.067) | 0.639 (0.065) | 1.60 (1.20–2.13) | ||||||||||
| aBMD UDR | 0.382 (0.063) | 0.404 (0.06) | 1.62 (1.21–2.17) | ||||||||||
| aBMD TR | 0.509 (0.062) | 0.534 (0.059) | 1.69 (1.26–2.27) | ||||||||||
| Gnudi S [ | Prospective cohort | Postmenopausal woman (female, mean age 58) | 254 | 5.47 ± 1.05 | 0 | 254 | 13 | Norland 2780 | BMD-DER -1SD | RR adjusted for age | 0.24 (0.02–2.64) | ||
| Gnudi S [ | Prospective cohort | Postmenopausal women who had BMD FN measurement at Modulo Dipartimentale di Medicina Interna, Istituti Ortopedici Rizzoli in Bologna, Italy (female, mean age 64.9) | 2235 | N/A | 108 | 1629 | N/A | Norland XR 36 pencil beam | aBMD FN | 674.1 (103.8) | 700 (107.7) | ||
| Greenfield DM [ | Cross-sectional | Postmenopausal women recruited at Northern General Hospital Trust, Sheffield, England (female, mean age 64.2) | 478 | N/A | 103 | 375 | N/A | Lunar DPX Densitometer | aBMD LS | 1.082 (0.17) | 1.069 (0.189) | ||
| aBMD FN | 0.858 (0.141) | 0.845 (0.134) | |||||||||||
| aBMD Troch | 0.783 (0.141) | 0.742 (0.134) | |||||||||||
| BMD WT | 0.75 (0.172 | 0.728 (0.167) | |||||||||||
| Ho PY [ | Case-control | Women aged > 60 years admitted with ankle fracture at University Teaching Hospital, Hong Kong between 2002 and 2003 (female, mean age 74) | N/A | N/A | 18 | N/A | N/A | Norland XR 36 | aBMD FN | −1.7 | −2.28 | ||
| aBMD LS | −1.67 | N/A | |||||||||||
| Ingle BM [ | Cross sectional | Postmenopausal women recruited at Northern General Hospital Trust, Sheffield, England (female, mean age 62.2) | 62 | N/A | 31 | 31 | N/A | Hologic QDR 1000/W | aBMD LS | 0.92 (0.06) | 0.92 (0.06) | ||
| aBMD 1/4 ankle | 0.73 (0.06) | 0.76 (0.04) | |||||||||||
| aBMD mid ankle | 0.61 (0.03) | 0.59 (0.03) | |||||||||||
| aBMD ultradistal ankle | 0.61 (0.03) | 0.6 (0.04) | |||||||||||
| aBMD total ankle | 0.64 (0.03) | 0.63 (0.03) | |||||||||||
| Lee DO [ | Cross-sectional | Patients visiting Myongji Hospital in Korean 2006–2015 (female and male, mean age 68.1) | 229 | N/A | 116 | 113 | N/A | Discovery W (Hologic) | aBMD LS | 0.837 (0.157) | 0.847 (0.157) | ||
| Morin SN [ | Retrospective cohort | Women undergoing baseline clinical BMD from 1990 to 2007 from the database of Manitoba, Canada (female, mean age 64.3) | 39991 | 5.3 | 1694 | 29878 | N/A | Lunar DPX Densitometer, Lunar Prodigy | HR adjusted for decades of age, FN BMD | 1.3 (1.08–1.57) | |||
| Pritchard JM [ | Prospective cohort | Females with or without DM from Population Health Information System (POPULIS) data repository at the Manitoba Centre for Health Policy (MCHP), Canada from 1987 to 2007 | 12205 | 4.8 | 559 | 11646 | 17 | Lunar DPX, Lunar Prodigy | aBMD FN | RR after multivariate for medical conditions and medication use | 0.91 (0.82, 1.01) | ||
| Schuit SC [ | Prospective cohort | Female and male aged at least 55 years old who participated in the Rotterdam study (female and male aged ≥ 55) | Total 5794 | 6.8 | Lunar DPX-L densitometer | HR age adjusted for predictive value of FN BMD per gender specific SD decrease | 1.2 (0.8–1.7) | ||||||
| Male 2437 | 6.8 | 1 (0.5–2.2) | |||||||||||
| Female 3357 | 6.8 | 1.1 (0.7–1.6) | |||||||||||
| Seeley DG [ | Prospective Cohort | Non-black women aged > 65 years from population-based listing from Baltimore, Minneapolis, The Monongahela Valley, Portland, USA (female, mean age 71.7) | 9704 | 5.9 ± 1.2 | 0 | 9704 | 191 | OsteoAnalyzer and Hologic QDR 1000 | aBMD DER | 0.35 (0.08) | 0.36 (0.09) | RR after multivariate analysis | 1.15 (0.98–1.35) |
| aBMD proximal radius | 0.63 (0.1) | 0.63 (0.1) | RR before multivariate analysis | 1.08 (0.93–1.26) | |||||||||
| aBMD calcaneus | 0.4 (0.1) | 0.4 (0.1) | 0.98 (0.85–1.14) | ||||||||||
| aBMD FN | 0.65 (0.11) | 0.64 (0.11) | 0.96 (0.82–1.13) | ||||||||||
| aBMD LS | 0.87 (0.6) | 0.85 (0.17) | 0.93 (0.8–1.08) | ||||||||||
| Stein EM [ | Cross-sectional | Postmenopausal women aged > 60 years old or more than 10 years past menopause were recruited at Columbia University Medical Center, or Helen Hayes Hospital (female, mean age 68.5) | 129 | N/A | 17 | 112 | N/A | Hologic QDR-4500, Lunar Prodigy | aBMD LS | 0.911 (0.021) | 0.927 (0.014) | ||
| aBMD TH | 0.809 (0.028) | 0.809 (0.012) | |||||||||||
| aBMD FN | 0.674 (0.022) | 0.684 (0.009) | |||||||||||
| aBMD 1/3R | 0.607 (0.024) | 0.613 (0.007) | |||||||||||
| aBMD UDR | 0.354 (0.016) | 0.379 (0.006) | |||||||||||
| Stone KL [ | Prospective cohort | Non-black U.S. women aged 65 and older from the study of osteoporotic fracture from Baltimore, Minneapolis, The Monongahela Valley, Portland, USA (female, mean age 71.7) | 9704 | 10.4 years (peripheral BMD), 8.5 years (central BMD) | 303 | OsteoAnalyzer and Hologic QDR 1000 | aBMD DER | HR age adjusted for predictive value | 1.28 (1.13–1.44) | ||||
| aBMD Proximal radius | 1.18 (1.05–1.33) | ||||||||||||
| aBMD calcaneus | 1.15 (1.02–1.3) | ||||||||||||
| aBMD LS | 1.1 (0.95–1.27) | ||||||||||||
| aBMD total hip | 1.07 (0.92–1.25) | ||||||||||||
| aBMD FN | 1.06 (0.92–1.23) |
aBMD, areal bone mineral density; LS, lumbar spine; FN, femoral neck; TH, total hip; DER, distal end radius; UDR, ultra-distal radius; TR, total radius; Troch, trochanter; WT, Ward’s triangle, 1/3R = 1/3 Radius; DM, diabetes mellitus; HR, hazard ratio; RR, relative risk; SD, standard deviation; N/A, not applicable.
Statistically significant; all ages are in years.